Cargando…

Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis

BACKGROUND: Oncolytic viruses (OVs) have shown prospects in advanced and metastatic cancer, and many clinical trials have been carried out. To compare OV therapies comprehensively and provide a categorized profile and ranking of efficacy and safety, a network meta-analysis was conducted. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Ruiyang, Bi, Xingang, Shang, Bingqing, Zhou, Aiping, Shi, Hongzhe, Shou, Jianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325792/ https://www.ncbi.nlm.nih.gov/pubmed/34332591 http://dx.doi.org/10.1186/s12985-021-01630-z

Ejemplares similares

Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety
por: Xie, Ruiyang, et al.
Publicado: (2022)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
por: Xie, Ruiyang, et al.
Publicado: (2022)

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target
por: Shang, Bingqing, et al.
Publicado: (2023)

Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study
por: Cao, Chuanzhen, et al.
Publicado: (2021)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy
por: Shang, Bingqing, et al.
Publicado: (2022)

A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus
por: Shang, Bingqing, et al.
Publicado: (2021)

Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
por: Zheng, Meijun, et al.
Publicado: (2019)

The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis
por: Gao, Peng, et al.
Publicado: (2021)

Efficacy and Safety of Oncolytic Viruses in Randomized Controlled Trials: A Systematic Review and Meta-Analysis
por: Li, Zengbin, et al.
Publicado: (2020)

The efficacy and safety assessment of oncolytic virotherapies in the treatment of advanced melanoma: a systematic review and meta-analysis
por: Wang, Changyuan, et al.
Publicado: (2023)

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies
por: Azad, Taha, et al.
Publicado: (2023)

Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective
por: Garmaroudi, Ghazal Asadi, et al.
Publicado: (2022)

Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice
por: Gil, M, et al.
Publicado: (2011)

Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
por: Chen, Lishu, et al.
Publicado: (2022)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
por: Liu, Xiangxing, et al.
Publicado: (2022)

Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015)

The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
por: Zolaly, Mohammed A, et al.
Publicado: (2023)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma
por: Shi, Hongzhe, et al.
Publicado: (2022)

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma
por: Kang, Xiangpeng, et al.
Publicado: (2020)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
por: Qu, Hong-Chen, et al.
Publicado: (2020)

Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
por: Martín-Carrasco, Clara, et al.
Publicado: (2022)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
por: Zhu, Licheng, et al.
Publicado: (2023)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Monitoring the Efficacy of Oncolytic Viruses via Gene Expression
por: Ansel, Ashley, et al.
Publicado: (2017)

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
por: Davola, Maria Eugenia, et al.
Publicado: (2019)

Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma
por: MacNeill, Amy L., et al.
Publicado: (2018)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database
por: Jiang, Weixing, et al.
Publicado: (2021)

Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
por: Jiang, Shan, et al.
Publicado: (2023)

Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors
por: Yoon, A-Rum, et al.
Publicado: (2022)

Oncolytic Sendai virus-based virotherapy for cancer: recent advances
por: Saga, Kotaro, et al.
Publicado: (2015)

Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
por: Hu, Henglong, et al.
Publicado: (2022)

Editorial: Recent advances in oncolytic virus therapy for brain tumors
por: Askari, Fatemeh Sana, et al.
Publicado: (2023)

Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022)

Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
por: Shen, Zhen, et al.
Publicado: (2023)

Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy
por: Park, Geon-Tae, et al.
Publicado: (2016)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_21tve82kokjoj8q16s9e98lg36